Identification of epigenetic mechanisms contributing to glioma drug resistance

2016/23/P/NZ2/04111

Keywords

Descriptors

  • NZ2_2: Genomika, transkryptomika i epigenomika
  • NZ2_8: Biologia obliczeniowa
  • NZ3_8: Komórki macierzyste

Panel

NZ2 – Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology

Host institution

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Jakub Karol Mieczkowski

Number of co-investigators in the project: 4

Call

POLONEZ 3 – announced on 2016-09-15

Amount awarded
946 464 PLN
Project start date
2017-09-01
Project end date
2019-08-31
Project duration
24 months (the same as in the proposal)
Project status
Project completed

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publications will be made available after the final report has been accepted.

European Commission logo This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 665778.

« New search

Graphic design and implementation: Jakub Piotrowski